Diabetes vaccine stumbles at second hurdle

Jun 27, 2011

An experimental vaccine to prevent progression of Type 1 diabetes failed at the second step of the three-phase trial process, doctors said on Monday in a study reported online by The Lancet.

The vaccine sought to protect insulin-producing beta cells in the pancreas from the body's immune system.

Its formula is based on an enzyme called glutamic acid decarboxylase (GAD), which the over-sensitised immune system targets -- and in doing so destroys the precious .

The idea was that by vaccinating patients with GAD, this would teach the immune system's to tolerate the enzyme.

The trial was carried out on 145 patients aged three to 45 years living in the United States and Canada who had been diagnosed with within the previous three months.

The volunteers were given either the vaccine; the vaccine plus a standard immune-system booster; or just the booster alone.

Patients in all three groups experienced similar progression in the disease, with no difference among them in side effects.

The paper, led by Jay Skyler of the University of Miami Miller School of Medicine, was presented at a conference of the in San Diego, California.

Despite the setback, the investigators called for more research to see if the formula might work when administered sooner or as part of a combination therapy.

The number of adults with diabetes worldwide has more than doubled since 1980, with almost 350 million now affected, according to data reported earlier at the conference.

Diabetes is caused by poor and can lead to heart disease and stroke and damage the kidneys, nerves and eyes.

High and diabetes kill three million people across the world each year.

The surge is attributed to longer lifespan and excess weight, especially among women.

Type 1, a condition that affects about five to 10 percent of people with diabetes, was previously known as juvenile diabetes because it typically shows up in children or young adults. Patients have to take daily insulin shots for the rest of their lives and follow dietary guidelines and exercise.

In Type 2 diabetes, previously known as adult-onset diabetes, either the body does not produce enough insulin or cells are resistant to the hormone. The condition is managed by diet, exercise as well as insulin shots if need be.

Explore further: Tackling illness in premature babies with genetics and artificial noses

add to favorites email to friend print save as pdf

Related Stories

Still hope for GAD diabetes vaccine

Jun 22, 2011

Despite the disappointing results in trying to treat children suffering from type 1 diabetes with the GAD vaccine, the treatment has not been written off entirely. DIAPREV-IT, the study in which healthy high-risk children ...

Gene therapy reverses type 1 diabetes in mice

Jun 21, 2010

Researchers have developed an experimental cure for Type 1 diabetes, a disease that affects about one in every 400 to 600 children and adolescents. They will present their results in a mouse model of Type 1 diabetes on Sunday ...

New clues to pancreatic cells' destruction in diabetes

Feb 03, 2009

Researchers have found what appears to be a major culprit behind the loss of insulin-producing β cells from the pancreases of people with diabetes, a critical event in the progression of the disease.

Potential preventative therapy for Type 1 diabetes

Apr 29, 2009

Scientists believe they may have found a preventative therapy for Type 1 diabetes, by making the body's killer immune cells tolerate the insulin-producing cells they would normally attack and destroy, prior to disease onset.

FDA approves new diabetes treatment

Oct 17, 2006

The U.S. Food and Drug Administration has approved the use of Januvia tablets as the first in a new class of diabetes drugs.

Recommended for you

New pain relief targets discovered

1 hour ago

Scientists have identified new pain relief targets that could be used to provide relief from chemotherapy-induced pain. BBSRC-funded researchers at King's College London made the discovery when researching ...

Building 'smart' cell-based therapies

2 hours ago

A Northwestern University synthetic biology team has created a new technology for modifying human cells to create programmable therapeutics that could travel the body and selectively target cancer and other ...

Proper stem cell function requires hydrogen sulfide

5 hours ago

Stem cells in bone marrow need to produce hydrogen sulfide in order to properly multiply and form bone tissue, according to a new study from the Center for Craniofacial Molecular Biology at the Herman Ostrow School of Dentistry ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

The_Cats_Pjamas
not rated yet Jun 28, 2011
"Diabetes is caused by poor blood sugar control and can lead to heart disease and stroke and damage the kidneys, nerves and eyes."

Not quite...
Poor blood sugar control can indeed lead to complications such as blindness, heart disease, etc. However, it doesn't cause diabetes.

Just thought it was best to clear that up.

More news stories

Researchers discover target for treating dengue fever

Two recent papers by a University of Colorado School of Medicine researcher and colleagues may help scientists develop treatments or vaccines for Dengue fever, West Nile virus, Yellow fever, Japanese encephalitis and other ...

Study recalculates costs of combination vaccines

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Hackathon team's GoogolPlex gives Siri extra powers

(Phys.org) —Four freshmen at the University of Pennsylvania have taken Apple's personal assistant Siri to behave as a graduate-level executive assistant which, when asked, is capable of adjusting the temperature ...

Better thermal-imaging lens from waste sulfur

Sulfur left over from refining fossil fuels can be transformed into cheap, lightweight, plastic lenses for infrared devices, including night-vision goggles, a University of Arizona-led international team ...

Deadly human pathogen Cryptococcus fully sequenced

Within each strand of DNA lies the blueprint for building an organism, along with the keys to its evolution and survival. These genetic instructions can give valuable insight into why pathogens like Cryptococcus ne ...